PL1602647T3 - Nowy związek zawierający jako podstawnik grupę 4-pirydyloalkilotio - Google Patents
Nowy związek zawierający jako podstawnik grupę 4-pirydyloalkilotioInfo
- Publication number
- PL1602647T3 PL1602647T3 PL04717833T PL04717833T PL1602647T3 PL 1602647 T3 PL1602647 T3 PL 1602647T3 PL 04717833 T PL04717833 T PL 04717833T PL 04717833 T PL04717833 T PL 04717833T PL 1602647 T3 PL1602647 T3 PL 1602647T3
- Authority
- PL
- Poland
- Prior art keywords
- substituent
- novel compound
- pyridylalkylthio group
- pyridylalkylthio
- group
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003062042 | 2003-03-07 | ||
| JP2004011602 | 2004-01-20 | ||
| EP04717833.0A EP1602647B1 (en) | 2003-03-07 | 2004-03-05 | Novel compound having 4-pyridylalkylthio group as substituent |
| PCT/JP2004/002812 WO2004078723A1 (ja) | 2003-03-07 | 2004-03-05 | ４－ピリジルアルキルチオ基を置換基として有する新規化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1602647T3 true PL1602647T3 (pl) | 2014-05-30 |
Family
ID=32964918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04717833T PL1602647T3 (pl) | 2003-03-07 | 2004-03-05 | Nowy związek zawierający jako podstawnik grupę 4-pirydyloalkilotio |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7534802B2 (pl) |
| EP (2) | EP2527326B1 (pl) |
| JP (1) | JP5183647B2 (pl) |
| ES (2) | ES2441176T3 (pl) |
| PL (1) | PL1602647T3 (pl) |
| TW (2) | TWI422583B (pl) |
| WO (1) | WO2004078723A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2527326B1 (en) | 2003-03-07 | 2014-10-08 | Santen Pharmaceutical Co., Ltd | Novel compounds having 4-pyridylalkylthio group as substituent |
| ES2368153T3 (es) * | 2004-02-17 | 2011-11-14 | Santen Pharmaceutical Co., Ltd. | Nuevo compuesto cíclico que presenta un grupo 4-piridilalquiltio que presenta amino (no) sustituido introducido en el mismo. |
| KR101179840B1 (ko) * | 2004-02-17 | 2012-09-04 | 산텐 세이야꾸 가부시키가이샤 | 치환 또는 무치환 아미노기를 도입한 4-피리딜알킬티오기를갖는 신규 고리형 화합물 |
| EP1854787B1 (en) * | 2005-03-03 | 2010-09-01 | Santen Pharmaceutical Co., Ltd. | Novel cyclic compound having quinolylalkylthio group |
| JP4585978B2 (ja) * | 2005-03-03 | 2010-11-24 | 参天製薬株式会社 | キノリルアルキルチオ基を有する新規環式化合物 |
| ES2548729T3 (es) | 2005-03-31 | 2015-10-20 | Santen Pharmaceutical Co., Ltd. | Nuevo compuesto cíclico que tiene grupo pirimidinilalquiltio |
| JP4834441B2 (ja) * | 2005-03-31 | 2011-12-14 | 参天製薬株式会社 | ピリミジニルアルキルチオ基を有する新規環式化合物 |
| WO2008093677A1 (ja) | 2007-01-29 | 2008-08-07 | Santen Pharmaceutical Co., Ltd. | 血管新生阻害活性を有する新規オキサジアゾール誘導体およびチアジアゾール誘導体 |
| TW200902533A (en) * | 2007-05-02 | 2009-01-16 | Boehringer Ingelheim Int | Carboxylic acid amides, manufacturing and use thereof as medicaments |
| EP2460787A1 (en) * | 2007-07-03 | 2012-06-06 | Astellas Pharma Inc. | Amide compounds and their use as PGE2 antagonists. |
| RU2479576C9 (ru) | 2008-05-14 | 2014-03-10 | Астеллас Фарма Инк. | Амидное соединение |
| KR102074089B1 (ko) | 2009-12-04 | 2020-02-05 | 선오비온 파마슈티컬스 인코포레이티드 | 다환형 화합물 및 이의 사용 방법 |
| JP7187437B2 (ja) | 2016-07-29 | 2022-12-12 | サノビオン ファーマシューティカルズ インク | 化合物および組成物ならびにそれらの使用 |
| EP3490607A4 (en) | 2016-07-29 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | COMPOUNDS AND COMPOSITIONS, AND USES THEREOF |
| MX390141B (es) | 2017-02-16 | 2025-03-20 | Sunovion Pharmaceuticals Inc | Metodos para tratar esquizofrenia |
| SG11202000669VA (en) | 2017-08-02 | 2020-02-27 | Sunovion Pharmaceuticals Inc | Isochroman compounds and uses thereof |
| CN112135827B (zh) | 2018-02-16 | 2024-01-12 | 赛诺维信制药公司 | 盐、晶型及其制备方法 |
| KR20210139376A (ko) | 2019-03-14 | 2021-11-22 | 선오비온 파마슈티컬스 인코포레이티드 | 이소크로마닐 화합물의 염, 및 이의 결정성 형태, 제조방법, 치료 용도 및 약제학적 조성물 |
| AU2020311940A1 (en) | 2019-07-11 | 2022-02-03 | ESCAPE Bio, Inc. | Indazoles and azaindazoles as LRRK2 inhibitors |
| WO2021211489A1 (en) | 2020-04-14 | 2021-10-21 | Sunovion Pharmaceuticals Inc. | (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders |
| CN119894509A (zh) * | 2022-09-09 | 2025-04-25 | 拉堤果生物医疗股份有限公司 | 钠通道阻断化合物、其衍生物和其使用方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE455684B (sv) | 1986-12-11 | 1988-08-01 | Sunds Defibrator | Anordning for kontinuerlig vegning av en fiberbana vid framstellning av fiberboard |
| DE3817170A1 (de) | 1987-05-22 | 1988-12-01 | Ernst Hans Hellmut | Klemmvorrichtung fuer das gurtband von kraftfahrzeugsicherheitsgurten |
| US4970224A (en) * | 1988-04-15 | 1990-11-13 | Rohm And Haas Company | 1-dimethylcarbamoyl-3-substituted-5-substituted-1H-1,2,4-triazzoles |
| JPH02129173A (ja) * | 1988-11-10 | 1990-05-17 | Ishihara Sangyo Kaisha Ltd | トリアゾール系化合物、それらの製造方法及びそれらを含有する有害生物防除剤 |
| DE3929673A1 (de) * | 1989-09-07 | 1991-03-14 | Bayer Ag | Substituierte carbamoyltriazole |
| JP2501051B2 (ja) | 1991-09-30 | 1996-05-29 | バンドー化学株式会社 | 搬送用ベルトの製造方法 |
| WO1997030035A1 (en) | 1996-02-13 | 1997-08-21 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| CO4950519A1 (es) | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
| WO1998050356A1 (en) | 1997-05-07 | 1998-11-12 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
| US6329372B1 (en) * | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| UA71587C2 (uk) | 1998-11-10 | 2004-12-15 | Шерінг Акцієнгезелльшафт | Аміди антранілової кислоти та їхнє застосування як лікарських засобів |
| JP3500401B2 (ja) | 1998-12-25 | 2004-02-23 | 譲治 田中 | 介護用電動歯ブラシ器 |
| HN2000000051A (es) * | 1999-05-19 | 2001-02-02 | Pfizer Prod Inc | Derivados heterociclicos utiles como agentes anticancerosos |
| US6495550B2 (en) * | 1999-08-04 | 2002-12-17 | Icagen, Inc. | Pyridine-substituted benzanilides as potassium ion channel openers |
| GB0001930D0 (en) | 2000-01-27 | 2000-03-22 | Novartis Ag | Organic compounds |
| US6995162B2 (en) | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
| EA200400648A1 (ru) * | 2001-11-08 | 2005-04-28 | Элан Фармасьютикалз, Инк. | N, n'-замещенные производные 1,3-диамино-2-гидроксипропана |
| US20050113450A1 (en) * | 2002-08-23 | 2005-05-26 | Atli Thorarensen | Antibacterial agents |
| US20040110802A1 (en) * | 2002-08-23 | 2004-06-10 | Atli Thorarensen | Antibacterial benzoic acid derivatives |
| EP2527326B1 (en) | 2003-03-07 | 2014-10-08 | Santen Pharmaceutical Co., Ltd | Novel compounds having 4-pyridylalkylthio group as substituent |
| HUP0304101A3 (en) * | 2003-12-22 | 2008-10-28 | Sanofi Aventis | Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates |
| KR101179840B1 (ko) | 2004-02-17 | 2012-09-04 | 산텐 세이야꾸 가부시키가이샤 | 치환 또는 무치환 아미노기를 도입한 4-피리딜알킬티오기를갖는 신규 고리형 화합물 |
-
2004
- 2004-03-05 EP EP11183799.3A patent/EP2527326B1/en not_active Expired - Lifetime
- 2004-03-05 WO PCT/JP2004/002812 patent/WO2004078723A1/ja not_active Ceased
- 2004-03-05 ES ES04717833.0T patent/ES2441176T3/es not_active Expired - Lifetime
- 2004-03-05 TW TW099120429A patent/TWI422583B/zh not_active IP Right Cessation
- 2004-03-05 PL PL04717833T patent/PL1602647T3/pl unknown
- 2004-03-05 EP EP04717833.0A patent/EP1602647B1/en not_active Expired - Lifetime
- 2004-03-05 ES ES11183799.3T patent/ES2527185T3/es not_active Expired - Lifetime
- 2004-03-05 US US10/548,283 patent/US7534802B2/en not_active Expired - Fee Related
- 2004-03-05 TW TW093105797A patent/TWI369353B/zh not_active IP Right Cessation
-
2009
- 2009-03-10 US US12/381,290 patent/US8207194B2/en not_active Expired - Fee Related
-
2010
- 2010-01-08 JP JP2010002879A patent/JP5183647B2/ja not_active Expired - Fee Related
-
2012
- 2012-04-18 US US13/449,921 patent/US8518973B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2527185T3 (es) | 2015-01-21 |
| TW201040159A (en) | 2010-11-16 |
| TW200510377A (en) | 2005-03-16 |
| US8518973B2 (en) | 2013-08-27 |
| EP1602647A1 (en) | 2005-12-07 |
| JP5183647B2 (ja) | 2013-04-17 |
| TWI369353B (en) | 2012-08-01 |
| JP2010116403A (ja) | 2010-05-27 |
| WO2004078723A1 (ja) | 2004-09-16 |
| EP2527326A1 (en) | 2012-11-28 |
| EP1602647B1 (en) | 2013-10-16 |
| US7534802B2 (en) | 2009-05-19 |
| EP1602647A4 (en) | 2009-07-01 |
| US20060194836A1 (en) | 2006-08-31 |
| US8207194B2 (en) | 2012-06-26 |
| EP2527326B1 (en) | 2014-10-08 |
| US20090286786A1 (en) | 2009-11-19 |
| US20120202817A1 (en) | 2012-08-09 |
| TWI422583B (zh) | 2014-01-11 |
| ES2441176T3 (es) | 2014-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL174375A0 (en) | Novel heterocyclic compounds as hsp90-inhibitors | |
| TWI369353B (en) | Novel compound having 4-pyridylalkylthio group as substituent | |
| GB0305927D0 (en) | Compound | |
| GB0306718D0 (en) | Compound | |
| EP1596860A4 (en) | NEW CONNECTIONS | |
| GB0324792D0 (en) | Compound | |
| GB0322629D0 (en) | Novel compound | |
| EP1648885A4 (en) | NEW CONNECTIONS | |
| GB0313677D0 (en) | Novel compound | |
| GB0317841D0 (en) | Compound | |
| GB0317842D0 (en) | Compound | |
| GB0302431D0 (en) | Novel compounds | |
| GB0302546D0 (en) | Novel compounds | |
| GB0304809D0 (en) | Novel compounds | |
| GB0327738D0 (en) | Novel compound | |
| GB0324599D0 (en) | Compound | |
| AU2003244179A8 (en) | Novel chromene compound | |
| GB0330013D0 (en) | Compound | |
| GB0315885D0 (en) | Compound | |
| GB0318347D0 (en) | Compound | |
| GB0328509D0 (en) | Compound | |
| GB0316107D0 (en) | Compound | |
| GB0300714D0 (en) | Compound | |
| GB0318345D0 (en) | Compound | |
| GB0306717D0 (en) | Compound |